Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: KanadaFázis nélkül

Stellate Ganglion Neuromodulation for the Treatment of Electrical Storm

A legfontosabb adatok

Ki végzi
Population Health Research Institute
Hol
Hamilton (Kanada)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
300 fő, tervezett
Kezdés
2027. jan.
Várható befejezés
2031. júl.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Stellate Ganglion Block Injection with Bupivicaine
  • Sham procedure control
A regiszteradat frissítve
2026. október 8.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults in intensive care with a VT storm, which means repeated dangerous fast heart rhythms. It tests a nerve block in the neck against a sham procedure.

Életkor
18 years or older
Nem
All sexes can join
A betegség stádiuma
3 or more VT/VF episodes within 24 hours, counting episodes stopped by a device shock or pacing. The last episode was less than 12 hr ago.
Korábbi kezelés
People who had a heart transplant or cardiac sympathetic denervation (CSD), a surgery on the heart nerves, cannot join.

A részvétel fő kizáró okai

  • Reasons a nerve block cannot be done, such as infection at the site, allergy to the drug, or a neck mass or neck cancer
  • VT storm caused by an inherited heart rhythm condition (LQTS, SQTS, Brugada, CPVT or CRDS)
  • Platelet count below 50,000 /µL
  • VT/VF during an acute heart attack before blood flow is restored, or VT storm from a reversible cause such as metabolic or drug-related
  • Consent cannot be obtained from the patient or a substitute decision maker

A regiszter feltételei, szó szerint

Mind a 10 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥18 years
  • ≥3 VT/VF episodes within 24 hours (including appropriate shock or antitachycardia pacing (ATP) terminated events) VT/VF episode definition: ventricular tachyarrhythmia episode ≥30 seconds in duration (VT or VF) requiring intervention regardless of duration, as captured on telemetry, ECG or device intracardiac electrogram
  • <12 hr since last VT/VF episode

Ki nem vehet részt

  • VT/VF occurring in the setting of acute coronary syndrome prior to revascularization
  • VT storm due to reversible causes (metabolic, drug mediated, etc.)
  • Standard clinical contraindications to nerve block (e.g., overlying site infection/allergy to the drug, cervical mass or history of neck cancer in the anticipated needle trajectory, others)
  • History of cardiac transplant or cardiac sympathetic denervation (CSD)
  • Platelet count <50,000 /µL
  • VT storm secondary to underlying ion channelopathies (LQTS, SQTS, Brugada, CPVT, or CRDS)
  • Inability to obtain consent (from patient OR substitute decision maker)

Helyszínek itt: Kanada

  • Population Health Research InstituteHamilton, KanadaContact: Project ManagerToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

Ventricular tachycardia (VT) is a serious heart rhythm problem in which the heart beats very fast and in an abnormal way. These abnormal heart rhythms can be life-threatening. When a person has three or more episodes of VT within a 24-hour period, it is called a "VT storm." VT storm can be difficult to treat because some patients do not respond well to standard medications. Some studies suggest that a procedure called a stellate ganglion block (SGB) may help. An SGB involves injecting a local anesthetic near a group of nerves in the neck that help control signals between the brain and the heart. The procedure can be performed at the bedside using ultrasound guidance.

A teljes eredeti leírásKevesebb

The purpose of this study is to find out whether SGB can delay or prevent the return of dangerous abnormal heart rhythms in patients with VT storm who are receiving care in an intensive care unit.

If a patient joins the study, they will be randomly assigned (by chance, like flipping a coin) to one of two groups. One group will receive a real stellate ganglion block. The other group will receive a sham procedure, in which a blunt needle will touch the skin but no injection will be given. Patients in the sham group who continue to experience VT may later receive the real procedure.

Participants will be followed until they leave the hospital or for 30 days after joining the study, whichever comes first. The study will take place at five hospitals across Ontario.

A vizsgálat 2 csoportja

  • Stellate Ganglion Block ArmA vizsgált kezelés

    SGB will be performed according to local practice. Local anesthesia will be delivered subcutaneously prior to the procedure. SGB should typically occurs under dynamic ultrasound guidance. Once a landmark for the SGB is identified (e.g., the C6 anterior tubercle), 10 mL of 0.5% bupivacaine will be injected into the left side of the neck using a 22-25G nerve block spinal needle ventral to the longus colli muscle and beneath the prevertebral fascia. This will be a one-time injection. The efficacy of the block will be assessed qualitatively by the operator at the time of the procedure. Any unused bupivacaine will be discarded. The procedure typically takes approximately 20 minutes.

    Kezelés: Stellate Ganglion Block Injection with Bupivicaine

  • Sham Procedure ArmSzínlelt kezelés, összehasonlításként

    The sham-procedure will use the identical preparatory and procedure steps as described for the active arm. The duration of the sham procedure will match that of the active intervention, and communication during the procedure will be standardized for both arms. Once the skin is draped and cleaned, control arm participants will have 1 mL of 0.5% bupivacaine injected, subcutaneously only. The operator will discard the unused bupivacaine to maintain blinding.

    Kezelés: Sham procedure control

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
STellate gangliOn neuRoModulatiOn For the Treatment oF Electrical Storm: a Randomized Sham-controlled Trial (STORM-OFF)
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. október 8.